128 related articles for article (PubMed ID: 37909291)
1. Adapted risk stratification and intensive chemotherapy abrogate the poor prognosis of pediatric B acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): a National cohort analysis.
Trinquand A; Betts DR; Harte S; Sills A; Rooney S; Barrett N; Storey L; Malone A; O'Marcaigh A; Smith OP
Leuk Lymphoma; 2024 Feb; 65(2):279-282. PubMed ID: 37909291
[No Abstract] [Full Text] [Related]
2. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA
J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221
[TBL] [Abstract][Full Text] [Related]
3. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
Tsuchiya KD; Davis B; Gardner RA
Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
[TBL] [Abstract][Full Text] [Related]
4. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21.
Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA
Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796
[TBL] [Abstract][Full Text] [Related]
5. Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease.
Harrison CJ
Blood; 2015 Feb; 125(9):1383-6. PubMed ID: 25608562
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.
Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M
Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457
[TBL] [Abstract][Full Text] [Related]
8. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.
Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468
[TBL] [Abstract][Full Text] [Related]
10. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
[TBL] [Abstract][Full Text] [Related]
11. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
Moorman AV; Robinson H; Schwab C; Richards SM; Hancock J; Mitchell CD; Goulden N; Vora A; Harrison CJ
J Clin Oncol; 2013 Sep; 31(27):3389-96. PubMed ID: 23940220
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
[TBL] [Abstract][Full Text] [Related]
13. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia.
Harrison CJ; Schwab C
Eur J Med Genet; 2016 Mar; 59(3):162-5. PubMed ID: 26836400
[TBL] [Abstract][Full Text] [Related]
14. Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Sinclair PB; Blair HH; Ryan SL; Buechler L; Cheng J; Clayton J; Hanna R; Hollern S; Hawking Z; Bashton M; Schwab CJ; Jones L; Russell LJ; Marr H; Carey P; Halsey C; Heidenreich O; Moorman AV; Harrison CJ
Haematologica; 2018 Apr; 103(4):634-644. PubMed ID: 29449437
[TBL] [Abstract][Full Text] [Related]
15. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
[TBL] [Abstract][Full Text] [Related]
16. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
Kim J; Lyu CJ; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia.
Ivanov Öfverholm I; Zachariadis V; Taylan F; Marincevic-Zuniga Y; Tran AN; Saft L; Nilsson D; Syvänen AC; Lönnerholm G; Harila-Saari A; Nordenskjöld M; Heyman M; Nordgren A; Nordlund J; Barbany G
Leuk Lymphoma; 2020 Mar; 61(3):604-613. PubMed ID: 31640433
[TBL] [Abstract][Full Text] [Related]
18. Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21.
Sharma R; Klairmont MM; Holland AC; Choi JK; Mullighan CG; Wang L; Sandlund JT; Pui CH; Inaba H
Pediatr Blood Cancer; 2020 Sep; 67(9):e28357. PubMed ID: 32469139
[No Abstract] [Full Text] [Related]
19. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21.
Verdoni AM; Zilla ML; Bullock G; Guinipero TL; Meade J; Yatsenko SA
Am J Med Genet A; 2022 Aug; 188(8):2325-2330. PubMed ID: 35678493
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).
Moorman AV; Richards SM; Robinson HM; Strefford JC; Gibson BE; Kinsey SE; Eden TO; Vora AJ; Mitchell CD; Harrison CJ;
Blood; 2007 Mar; 109(6):2327-30. PubMed ID: 17095619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
